NCT04065009View on ClinicalTrials.gov

The IPLA-OVCA Trial, Intra-Peritoneal Local Anaesthetics in Ovarian Cancer

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

August 26, 2020

Primary Completion Date

January 10, 2024

Study Completion Date

August 26, 2028

Conditions
Advanced Ovarian Cancer
Interventions
DRUG

Ropivacaine

Experimental drug will be administered intraperitoneally

DRUG

Saline Solution

Placebo will be administered intraperitoneally

Trial Locations (1)

17176

Karolinska Hospital, Solna, Stockholm

All Listed Sponsors
collaborator

Skane University Hospital

OTHER

lead

Karolinska Institutet

OTHER

NCT04065009 - The IPLA-OVCA Trial, Intra-Peritoneal Local Anaesthetics in Ovarian Cancer | Biotech Hunter | Biotech Hunter